Latest filing published 21 Feb 2025 for Immunovant, Inc., €41k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William L. Macias: trading record in brief
All filings by William L. Macias on record concern Immunovant, Inc., in the capacity of senior executive. Between 11 June 2021 and 19 February 2025, the trades on record add up to 41 filings.
On the market, this insider has only sold: 35 sales, €2.1M in total. Outside the open market, there are 6 share grants. 2025 to date brings no purchases and 5 sales.
On 21 February 2025 came the latest disclosure, an open-market sale for €41k in Immunovant, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William L. Macias
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,055 shares@ US$20.862.7% of flowCommon StockSEC:0001764013-25-000032:0
- 1,883 shares@ US$23.812.9% of flowCommon StockSEC:0001764013-25-000015:0
- 3,353 shares@ US$25.455.4% of flowCommon StockSEC:0001764013-24-000195:0
- 2,627 shares@ US$28.794.6% of flowCommon StockSEC:0001764013-24-000173:0
- 2,907 shares@ US$31.845.5% of flowCommon StockSEC:0001764013-24-000159:0
- 2,362 shares@ US$29.644.3% of flowCommon StockSEC:0001764013-24-000136:0
- 3,247 shares@ US$29.655.9% of flowCommon StockSEC:0001764013-24-000096:0
- 6,136 shares@ US$28.8011.0% of flowCommon StockSEC:0001764013-24-000081:0
- 54,978 shares0Common StockSEC:0001764013-24-000053:0
- 2,221 shares@ US$36.154.9% of flowCommon StockSEC:0001764013-24-000039:0
- 424 shares@ US$41.031.1% of flowCommon StockSEC:0001764013-24-000014:0
- 3,141 shares@ US$32.756.3% of flowCommon StockSEC:0001764013-23-000139:0
- 530 shares@ US$36.801.2% of flowCommon StockSEC:0001764013-23-000122:0
- 12,332 shares@ US$20.3015.4% of flowCommon StockSEC:0001764013-23-000099:0
- 426 shares@ US$24.940.6% of flowCommon StockSEC:0001764013-23-000082:0
- 509 shares@ US$16.290.5% of flowCommon StockSEC:0001764013-23-000061:0
- 87,664 shares0Common StockSEC:0001764013-23-000039:0
- 537 shares@ US$18.240.6% of flowCommon StockSEC:0001764013-23-000024:0
- 120 shares@ US$15.110.1% of flowCommon StockSEC:0001764013-23-000006:0
- 341 shares@ US$9.670.2% of flowCommon StockSEC:0001764013-22-000134:0
- 112,816 shares0Common StockSEC:0001764013-22-000105:0
- 322 shares@ US$4.700.1% of flowCommon StockSEC:0001764013-22-000074:0
- 1,392 shares@ US$4.980.5% of flowCommon StockSEC:0001764013-22-000039:0
- 26,813 shares@ US$8.2815.1% of flowCommon StockSEC:0001764013-22-000004:0
- 112,108 shares0Common StockSEC:0001764013-21-000121:0
25 of 26 declarations
